Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pioglitazone vs Metformin on Bone Health in T2DM
NCT01935804Phase 2Completed
- Sponsor
- King Abdulaziz University
- Start
- Jan 2009
- Primary completion
- Jan 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of pioglitazone in type 2 diabetes mellitus (T2DM), sponsored by King Abdulaziz University. Primary endpoint: Mean percentage change in Bone Mineral Density at 12 months. Started Jan 2009; status: completed.
02
Drugs
pioglitazone
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01935804.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01935804.